Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03260023
Title Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Transgene
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP

Facility Status City State Zip Country Details
Mayo Clinic Jacksonville Florida 32224 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
I.C.O. Paul Papin Angers France Details
CHU Besançon Besançon France Details
Hôpital Saint André - CHU de Bordeaux Bordeaux France Details
Hôpitaux Civils de Colmar - Hôpital Pasteur Colmar France Details
CLCC Georges-François Leclerc Dijon France Details
Centre Léon Bérard Lyon France Details
Hopital de la Timone Marseille France Details
Institut Curie Paris France Details
I.C.O. Gauducheau Saint-Herblain France Details
Centre Paul Strauss - ICANS - Institut de cancérologie Strasbourg Europe Strasbourg France Details
Institut Claudius Regaud - IUCT - Oncopole Toulouse France Details
Institut Gustave Roussy Villejuif France Details
ICO Badalona - Hospital Germans Trias i Pujol Badalona Spain Details
Hospital Virgen de las Nieves Granada Spain Details
Fundación de Investigación biomédica H. 12 de Octubre Madrid Spain Details
Fundación de Investigación Biomédica Hospital Clínico San Carlos Madrid Spain Details
Hospital Virgen de La Victoria Malaga Spain Details
Hospital General de Valencia Valencia Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field